title: Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy.
authors.forename: Allan J
authors.initials: AJ
authors.lastname: Pantuck
authors.forename: Nazy
authors.initials: N
authors.lastname: Zomorodian
authors.forename: Arie S
authors.initials: AS
authors.lastname: Belldegrun